Chris Halyk
Director/Board Member bei MEDIPHARM LABS CORP.
Vermögen: 5 418 $ am 31.03.2024
Profil
Chris Halyk is an Independent Director at MediPharm Labs Corp.
He was previously the President at Janssen, Inc. and held the position from 2006 to 2019.
Prior to that, he was the Managing Director at Ortho Biotech, Inc. and the Director at Innovative Medicines Canada.
Mr. Halyk completed his undergraduate degree at Richard Ivey School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MEDIPHARM LABS CORP.
0,02% | 22.12.2023 | 86 000 ( 0,02% ) | 5 418 $ | 31.03.2024 |
Aktive Positionen von Chris Halyk
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDIPHARM LABS CORP. | Director/Board Member | 04.08.2020 |
Ehemalige bekannte Positionen von Chris Halyk
| Unternehmen | Position | Ende |
|---|---|---|
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | President | 01.01.2019 |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Director/Board Member | 01.01.2013 |
| Ortho Biotech, Inc. | Corporate Officer/Principal | - |
Ausbildung von Chris Halyk
| Richard Ivey School of Business | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MEDIPHARM LABS CORP. | Process Industries |
| Private Unternehmen | 3 |
|---|---|
| Ortho Biotech, Inc. | |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
